Libivirumab is a human monoclonal antibody directed against the hepatitis B virus. WHO Drug Information Shouval D, Terrault N, Galun E, Samuel D, Gane...
2 KB (77 words) - 20:34, 1 December 2023
protein (TRAP) inflammatory diseases Lexatumumab mab human TRAIL-R2 cancer Libivirumab mab human hepatitis B surface antigen hepatitis B Lifastuzumab vedotin...
136 KB (4,020 words) - 06:13, 27 September 2024
Diridavumab§ Etesevimab† Exbivirumab§ Foravirumab§ Imdevimab† (+casirivimab) Libivirumab§ Maftivimab Nirsevimab† Odesivimab Pemivibart Rafivirumab§ Regavirumab§...
24 KB (2,642 words) - 21:23, 27 September 2024
(INN) liatermin (INN) libecillide (INN) libenzapril (INN) Libervant libivirumab (INN) Librelease Libritabs Librium licostinel (INN) lidamidine (INN)...
4 KB (273 words) - 06:32, 15 August 2024
Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B...
2 KB (93 words) - 20:34, 1 December 2023